Vaccines

Learning from past failures in the development of staph vaccines may inform how other vaccines for common bugs should be developed

On this episode of the COVID, Quickly podcast, we talk about getting reinfected with the coronavirus just a month or two after an earlier bout—and the difference that trusting others can make in a pandemic.

An unvaccinated person became infected with the virus, which can be traced to a live, weakened virus commonly used in the oral polio vaccine abroad

From symptoms to vaccines and treatment, here are some fast facts about monkeypox.

On this episode of the COVID, Quickly podcast, we talk about the increase in new Omicron subvariants. Should fall vaccine boosters contain standard Omicron or some of those new subvariants instead?

Developing nations that desperately need these more effective vaccines are virtually locked out

The FDA has called for updating COVID vaccines to address the Omicron subvariants BA.4 and BA.5. But will the shots keep up with the virus?

The model, which uses machine learning to track the fitness of different viral strains, accurately predicted the rise of Omicron’s BA.2 subvariant and the Alpha variant

On this episode of the COVID, Quickly podcast, we discuss some parents breathing a collective sigh of relief and the paradox of how effective vaccines can make it harder to create new drugs to treat patients who get the coronavirus.

An advisory committee voted unanimously to recommend authorizing the Moderna and Pfizer shots for the youngest children

On this episode of the COVID, Quickly podcast, we clear up some data misconceptions, get to the bottom of the booster uptake issue and talk Novavax.

Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.

You can listen to all past episodes here.